Advisory Services Network’s Acumen Pharmaceuticals ABOS Stock Holding History

Advisory Services Network’s Portfolio ABOS Stock Details ABOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.62K	Buy	+1,111	New	+$2.83K	﹤0.01%	4069
2025 Q4	–	Sell	-1,111	Closed	-$1.9K	–	1809
2025 Q3	$1.9K	Buy	+1,111	New	+$1.54K	﹤0.01%	3810
2024 Q1	–	Sell	-1,000	Closed	-$3.84K	–	1459
2023 Q4	$3.84K	Buy	+1,000	New	+$2.97K	﹤0.01%	3199

Other funds holding ABOS

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

SCV

Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

KIA

Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Advisory Services Network's ABOS Position: Q1 2026 in Review

Advisory Services Network opened a new position in Acumen Pharmaceuticals (ABOS) in Q1 2026: 1,111 shares worth $2.62K. The stake represents ﹤0.01% of the portfolio and ranks #4069 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in ABOS as recently as Q3 2025.

Advisory Services Network first reported a position in ABOS in Q4 2023 and has held it in 3 quarters since. The position peaked at $3.84K in Q4 2023. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

Advisory Services Network held 1,111 shares of Acumen Pharmaceuticals worth $2.62K as of Q1 2026.
Acumen Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
Acumen Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4069 holding.
Advisory Services Network first reported a position in Acumen Pharmaceuticals in Q4 2023 and has held it in 3 quarters since.
Advisory Services Network's Acumen Pharmaceuticals position peaked at $3.84K in Q4 2023.
84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.